-
Absolute Antibody Partners with the Recombinant Antibody Network to Facilitate Access to Engineered Recombinant Antibodies
Dec 3, 2019, 10:17 AM by Michael CroftREDCAR, UNITED KINGDOM - Dec 3, 2019 - Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with the Recombinant Antibody Network (RAN), a consortium of three expert centers at the University of Chicago, University of Toronto, and UC San Francisco (UCSF) with a common goal to generate recombinant antibodies at a proteome-wide scaleFull story -
Metrion Biosciences and LifeArc extend ion channel drug discovery collaboration to accelerate neuroscience-focused research
Dec 3, 2019, 07:47 AM by Michael CroftCAMBRIDGE AND LONDON, UNITED KINGDOM - Dec 3, 2019 - Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, and LifeArc, a leading UK independent medical research charity, today announced an extension of their neuroscience-focused ion channel drug discovery collaboration, following the success of the initial twelve-month agreementFull story -
Hypha Discovery announces “One-Stop Metabolite Shop” solution to support pharmaceutical and agrochemical R&D
Dec 3, 2019, 05:22 AM by Michael CroftSLOUGH, UK - Dec 3, 2019 - Hypha Discovery Limited, a leading specialist CRO, has launched its One-Stop Metabolite Shop to provide a complete solution for provision of small molecule drug metabolites to pharmaceutical and agrochemical companies worldwideFull story -
Benchling: Enabling the Next Generation of Data and Workflow Tracking
Dec 2, 2019, 10:35 AM by Michael CroftBio-IT World Benchling’s value proposition is easy to see. For researchers—whether in an academic lab, small biotech, or big pharma—keeping track of research using paper lab notebooks, email, and spreadsheets is cumbersome and inefficient. But the challenges to science are much bigger than just misplaced notes or forgotten results. The real value, says Saji Wickramasekara, comes from enabling a new level of collaboration and data provenance.Full story -
TrialScope Launches Clinical Trials Website for EMD Serono
Dec 2, 2019, 09:31 AM by Michael CroftJERSEY CITY, NJ, UNITED STATES - Dec 2, 2019 - TrialScope, the global leader in clinical trial transparency and disclosure compliance solutions, has worked with EMD Serono, the North American branch of the healthcare business of Merck KGaA, Darmstadt, Germany, to launch a new website, https://clinicaltrialsFull story -
One Nucleus announces finalists of the BioNewsRound Award
Nov 28, 2019, 06:24 AM by Michael CroftLONDON, UK - Nov 28, 2019 - One Nucleus reveals the finalists of its annual BioNewsRound Award, recognising life science companies that have announced exciting developments for patients and the sectorFull story -
Creative Peptides Provides Photo Cross Linkers for Custom Labeling in Peptide Modification
Nov 27, 2019, 22:22 PM by Michael CroftNY, NY, UNITED STATES - Nov 28, 2019 - The global leading peptide supplier Creative Peptides announces to release a product line of photo cross linkers for researchers who are engaged with custom labeling, peptide bioconjugation as well as peptide modificationFull story -
Enzymes for Cancer Treatment Manufactured by Creative Enzymes Have Set New Pace for Medical Science
Nov 27, 2019, 22:08 PM by Michael CroftNEW YORK, NY - Nov 28, 2019 - Creative Enzymes, a cutting-edge enzyme product and service provider based in NY, USA, has recently published enzymes for cancer treatment to help scientists in the area of medicineFull story -
BOC Sciences Rearranges Chemical Analysis and Purification Service for Drug Discovery Projects
Nov 27, 2019, 21:06 PM by Michael CroftSHIRLEY, NY, NY, UNITED STATES - Nov 28, 2019 - In response to the ever-increasing demand in new drug discovery and development, medicinal chemistry has progressed at a fast pace during the last ten yearsFull story -
Signant Health Joins the Association of Clinical Research Organizations (ACRO) to Add a Technology Perspective to Industry Conversations
Nov 27, 2019, 11:09 AM by Michael CroftPHILADELPHIA, PA - Nov 27, 2019 - Signant Health announced today that it has joined the non-profit Association of Clinical Research Organizations (ACRO)Full story -
HudsonAlpha, Vanderbilt, Thermo Scientific, and More: News From November 2019
Nov 27, 2019, 08:40 AM by Michael CroftFull storyBio-IT World | November featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including HudsonAlpha, Vanderbilt, Thermo Scientific, and more.
-
Prokarium announces MHRA acceptance to run Phase I trial of lead vaccine against enteric fever
Nov 26, 2019, 04:50 AM by Michael CroftLONDON, UK - Nov 26, 2019 - Prokarium, a private biotechnology company developing vaccines against infectious diseases and immunotherapy for solid tumors, has received Clinical Trial Authorization (CTA) acceptance from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to run a first-in-human Phase I trial with Entervax, a bivalent vaccine against enteric feverFull story -
SAKOR Technologies Announces Dynamometer Line for Testing Electric Motor Efficiency to Meet International Environmental Standards
Nov 25, 2019, 14:27 PM by Michael CroftOWOSSO, MI, UNITED STATES - Nov 25, 2019 - For Immediate ReleaseContact: Judi Handel McNeil, Gray & Rice 617-367-0100 extFull story -
Explosion Of Interest In Organ-On-A-Chip Technology
Nov 25, 2019, 09:05 AM by Michael CroftFull storyBio-IT World | Organ-on-a-chip models were practically nonexistent a decade ago, but significant advances are now being made every few months.
-
Debiopharm Implements Dotmatics to Improve Data-Driven Decision-Making
Nov 25, 2019, 06:10 AM by Michael CroftBISHOP'S STORTFORD, UNITED KINGDOM - Nov 25, 2019 - Debiopharm International SA, the drug development company focused on oncology and infectious diseases, has implemented tools from Dotmatics, a leading provider of scientific informatics solutions and services, to re-engineer its data management processes to support its continuous growthFull story -
Potential findings on whole genome sequencing for cancer treatment was made
Nov 24, 2019, 16:39 PM by Michael CroftSHIRLEY, NY, UNITED STATES - Nov 25, 2019 - In recent years, individualized treatments will benefit more cancer patients as the time and cost of whole genome sequencing decreasesFull story -
Follow The Money: Investments and Funding Rounds for November
Nov 22, 2019, 14:30 PM by Michael CroftFull storyBio-IT World | Some of the latest funding updates from across life sciences, clinical trials, the diagnostics industries.
-
Hesperos: A CRO For Body-On-A-Chip Enthusiasts
Nov 22, 2019, 08:00 AM by Michael CroftFull storyBio-IT World | Operationally, Hesperos works much like a contract research organization that delivers study results back to sponsoring companies, with its specialty being integration assistance to drug developers interested in using a multiorgan model for their preclinical efficacy and toxicity studies.
-
Spring Bank Announces Dosing of Patients in Phase 1 Clinical Trial of IV-Administered STING Agonist, SB 11285
Nov 21, 2019, 09:42 AM by Michael CroftHOPKINTON, MA, UNITED STATES - Nov 20, 2019 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced that it has initiated dosing patients in a Phase 1 trial of SB 11285, the companys intravenously (IV)-administered STING (STimulator of INterferon Gene) agonistFull story -
Certara Announces the Availability of PK Submit, its Pharmacokinetic CDISC Technology Solution
Nov 21, 2019, 09:03 AM by Michael CroftPRINCETON, NJ - Nov 21, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the availability of PK Submit, a technology solution for automating the creation of PK Clinical Data Interchange Standards Consortium (CDISC) domains during Non-Compartmental Analysis (NCA)Full story